Global Influenza Vaccine Market Research Report 2023(Status and Outlook)

Global Influenza Vaccine Market Research Report 2023(Status and Outlook)



Report Overview

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Global Influenza Vaccine main players include CSL, GSK, Sanofi Pasteur, Mylan, Hulan Bio, AstraZeneca, CCBIO, etc., totally accounting for about 95% of market. North America is the largest market of Influenza Vaccine, with a share over 55%. As for the types of products, it can be divided into Trivalent Influenza Vaccine and Quadrivalent Influenza Vaccine. The most common product is Quadrivalent Influenza Vaccine, with a share over 95%. In terms of applications, it is widely used in For Children (6 months to 3 years) and For Adults and Children over 3 years. The most application is in Adults and Children over 3 years, with a share over 73%.

The Global Influenza Vaccine Market Size was estimated at USD 5154.00 million in 2022 and is projected to reach USD 6691.54 million by 2029, exhibiting a CAGR of 3.80% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Influenza Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Vaccine market in any manner.

Global Influenza Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

CSL

GSK

Sanofi Pasteur

Mylan

Hulan Bio

AstraZeneca

CCBIO

Market Segmentation (by Type)

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

Market Segmentation (by Application)

Onshore

Offshore

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Influenza Vaccine Market

Overview of the regional outlook of the Influenza Vaccine Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Influenza Vaccine
1.2 Key Market Segments
1.2.1 Influenza Vaccine Segment by Type
1.2.2 Influenza Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Influenza Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Influenza Vaccine Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Influenza Vaccine Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Influenza Vaccine Market Competitive Landscape
3.1 Global Influenza Vaccine Sales by Manufacturers (2018-2023)
3.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.3 Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Influenza Vaccine Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Influenza Vaccine Sales Sites, Area Served, Product Type
3.6 Influenza Vaccine Market Competitive Situation and Trends
3.6.1 Influenza Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Influenza Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Influenza Vaccine Industry Chain Analysis
4.1 Influenza Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Influenza Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Influenza Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Vaccine Sales Market Share by Type (2018-2023)
6.3 Global Influenza Vaccine Market Size Market Share by Type (2018-2023)
6.4 Global Influenza Vaccine Price by Type (2018-2023)
7 Influenza Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Vaccine Market Sales by Application (2018-2023)
7.3 Global Influenza Vaccine Market Size (M USD) by Application (2018-2023)
7.4 Global Influenza Vaccine Sales Growth Rate by Application (2018-2023)
8 Influenza Vaccine Market Segmentation by Region
8.1 Global Influenza Vaccine Sales by Region
8.1.1 Global Influenza Vaccine Sales by Region
8.1.2 Global Influenza Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Influenza Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Influenza Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Influenza Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Influenza Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Influenza Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 CSL
9.1.1 CSL Influenza Vaccine Basic Information
9.1.2 CSL Influenza Vaccine Product Overview
9.1.3 CSL Influenza Vaccine Product Market Performance
9.1.4 CSL Business Overview
9.1.5 CSL Influenza Vaccine SWOT Analysis
9.1.6 CSL Recent Developments
9.2 GSK
9.2.1 GSK Influenza Vaccine Basic Information
9.2.2 GSK Influenza Vaccine Product Overview
9.2.3 GSK Influenza Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Influenza Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi Pasteur
9.3.1 Sanofi Pasteur Influenza Vaccine Basic Information
9.3.2 Sanofi Pasteur Influenza Vaccine Product Overview
9.3.3 Sanofi Pasteur Influenza Vaccine Product Market Performance
9.3.4 Sanofi Pasteur Business Overview
9.3.5 Sanofi Pasteur Influenza Vaccine SWOT Analysis
9.3.6 Sanofi Pasteur Recent Developments
9.4 Mylan
9.4.1 Mylan Influenza Vaccine Basic Information
9.4.2 Mylan Influenza Vaccine Product Overview
9.4.3 Mylan Influenza Vaccine Product Market Performance
9.4.4 Mylan Business Overview
9.4.5 Mylan Influenza Vaccine SWOT Analysis
9.4.6 Mylan Recent Developments
9.5 Hulan Bio
9.5.1 Hulan Bio Influenza Vaccine Basic Information
9.5.2 Hulan Bio Influenza Vaccine Product Overview
9.5.3 Hulan Bio Influenza Vaccine Product Market Performance
9.5.4 Hulan Bio Business Overview
9.5.5 Hulan Bio Influenza Vaccine SWOT Analysis
9.5.6 Hulan Bio Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Influenza Vaccine Basic Information
9.6.2 AstraZeneca Influenza Vaccine Product Overview
9.6.3 AstraZeneca Influenza Vaccine Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 CCBIO
9.7.1 CCBIO Influenza Vaccine Basic Information
9.7.2 CCBIO Influenza Vaccine Product Overview
9.7.3 CCBIO Influenza Vaccine Product Market Performance
9.7.4 CCBIO Business Overview
9.7.5 CCBIO Recent Developments
10 Influenza Vaccine Market Forecast by Region
10.1 Global Influenza Vaccine Market Size Forecast
10.2 Global Influenza Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Influenza Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Influenza Vaccine Market Size Forecast by Region
10.2.4 South America Influenza Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Influenza Vaccine by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Influenza Vaccine Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Influenza Vaccine by Type (2024-2029)
11.1.2 Global Influenza Vaccine Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Influenza Vaccine by Type (2024-2029)
11.2 Global Influenza Vaccine Market Forecast by Application (2024-2029)
11.2.1 Global Influenza Vaccine Sales (K MT) Forecast by Application
11.2.2 Global Influenza Vaccine Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings